Nolte Alexander 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Nolte Alexander
Chief Accounting Officer
Transactions
- Other
Common Stock
2022-01-31$12.39/sh+968$11,994→ 968 total - Sale
Common Stock
2022-02-01$16.65/sh−968$16,117→ 0 total - Award
Stock Options (Right to buy)
2022-02-02$15.79/sh+30,000$473,700→ 30,000 totalExercise: $15.79Exp: 2032-02-02→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 968 shares by the Reporting Person on 01/31/2022 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option shall vest monthly over a four-year period.